A CoreWeave-linked CRWV contract on Hyperliquid weakened amid Texas governor vote counts, as Democratic candidate Gina Hinojosa, who supports pausing new data center approvals and ending tax breaks, led in votes. CoreWeave has significant data center projects in Texas, including a large campus in West Texas with ongoing expansion. A trader opened a $500,000 short position on the contract during this period, reflecting market uncertainty about the impact of potential policy changes on data center operations in the state.
The CoreWeave-linked Hyperliquid contract is the subject, with Pluang market data provided as context. For readers following major cryptocurrencies on Pluang, as of Nov 05, 2026 00:31 WIB, 45 of 50 priced major cryptocurrencies rose while 4 fell. Notable movers include SXP (Solar) down 46.27% at Rp37, BAL (Balancer) up 11.14% at Rp16.297, and BAT (Basic Attention Token) up 10.32% at Rp2.532 with a sell order activity of 83%.
Goldman Sachs Group, Inc. disclosed that it briefly held a combined stake exceeding 3% in Ontex Group NV shares as of October 27, 2026, with 566,115 voting rights and 1,965,157 financial instruments. However, by October 28, 2026, their combined posit...
BNP Paribas announced its monthly declaration of voting rights and shares as of October 31, 2026. The bank reported a total of 1,101,600,607 shares and an equal number of voting rights. This update is part of regulatory compliance under French commer...
Ontex disclosed that Goldman Sachs Group, Inc. crossed the 3% ownership threshold in Ontex shares on October 27, 2026, holding a combined total of 3.07% including voting rights and financial instruments. However, the next day, October 28, 2026, Goldm...
Neion Bio has appointed John A. Maga, Ph.D., as Head of Biologics and CMC to lead the development of biologic medicines using its Raptor platform, which produces proteins in transgenic chicken eggs. Maga brings over 25 years of biopharmaceutical expe...
The National Advertising Division (NAD) recommended that Good Life Meds discontinue claims about health benefits and personalization for its compounded Tirzepatide+ weight loss products after a challenge by Eli Lilly. NAD found that Good Life lacked ...
